FDA: Atazanavir Label Updated
The Reyataz (atazanavir) package insert has been updated to include important drug-drug interaction information regarding the administration of Reyataz with or without ritonavir and nevirapine, efavirenz, hormonal contraceptives, orally and parenterally administered midazolam, H2-receptor antagonists and drugs that are substrates of cytochrome P450 2C8. For more information, read the FDAnbsp;press releasenbsp;and the AIDSinfo atazanavir drug fact sheet. (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))

Woman in two-hour ambulance wait
An 86-year-old woman who lives yards from a hospital in Essex waits nearly two hours for an ambulance to arrive at her house. (Source: BBC News | Health | UK Edition)